GLP-1 analogues for neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial

BACKGROUND: Attenuating the neurological damage occurring after out-of-hospital cardiac arrest is an ongoing research effort. This dual-centre study investigates the neuroprotective effects of the glucagon-like-peptide-1 analogue Exenatide administered within 4 hours from the return of spontaneous c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiberg, Sebastian, Hassager, Christian, Thomsen, Jakob Hartvig, Frydland, Martin, Høfsten, Dan Eik, Engstrøm, Thomas, Køber, Lars, Schmidt, Henrik, Møller, Jacob Eifer, Kjaergaard, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929765/
https://www.ncbi.nlm.nih.gov/pubmed/27363489
http://dx.doi.org/10.1186/s13063-016-1421-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929765/
https://www.ncbi.nlm.nih.gov/pubmed/27363489
http://dx.doi.org/10.1186/s13063-016-1421-2

Ejemplares similares